MedTrace Logo

Evaluation and Comparison of a Novel Dentrifice Formulation on Plaque Removal

NCT06082869 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2023-10-13

No results posted yet for this study

Summary

To evaluate and compare plaque removal efficacy and safety of a novel dentifrice formulation immediately after the first supervised use and following one week of twice, daily use at home.

Conditions

  • Dental Plaque

Interventions

DRUG

Protegera™ toothpaste (NaF)

Plaque Reduction

DRUG

Crest™ Cavity Protection toothpaste (NaF)

Plaque Reduction

Sponsors & Collaborators

  • Protegera, Inc.

    lead INDUSTRY

Principal Investigators

  • Jeffery L Milleman, DDS, MPA · Salus Research, Inc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-02-23
Completion
2023-02-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06082869 on ClinicalTrials.gov